Axogen

AXGNNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$2.922 B

$48.92 -4.73%

Close of 6 Nov 2026

As of 6 Nov 2026, Axogen (AXGN) has a market capitalization of $2.92B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$225.2M

#2237 by revenue

Earnings

-$15.7M

Loss-making

Shares outstanding

59,730,715

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#2LivaNovaLIVN$5.03B
#3IntegerITGR$4.31B
#4AxogenAXGN$2.92B
#5TransMedics GroupTMDX$2.40B
#6CONMEDCNMD$1.57B

What if Axogen were worth as much as…

Open the what-if tool →

Gold $28.2T

$472,736.24

Per share 9,663× higher

Bitcoin $1.53T

$25,578.93

Per share 523× higher

Apple $5.02T

$83,973.26

Per share 1,717× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Axogen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.